Tag : ADA

Neurology

ADA Advises Wider Use of Newer Glucose-Lowering Drugs

Newsemia
In the 2020 Standards of Care, the American Diabetes Association advises consideration of SGLT2 inhibitors and GLP-1 receptor agonists in patients with high CVD or...
Neurology

New ADA Update: Liraglutide for Youth and Technology Issues

Newsemia
Liraglutide for youth, dulaglutide cardiovascular outcomes data, and ‘time-in-range’ guidelines inform the latest Living Standards updates. Medscape Medical News Source link...
Latest News

Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions

Newsemia
SAN DIEGO–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24TNDM&src=ctag" target="_blank">$TNDM</a> <a href="https://twitter.com/hashtag/TNDM?src=hash" target="_blank">#TNDM</a>–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy